rss
Arch Dis Child doi:10.1136/archdischild-2011-300294
  • PostScript
  • Letters

Quality of published case reports on adverse drug reactions in children

  1. Massimiliano Mucci
  1. Safety Evaluation and Reporting, Worldwide Safety and Regulatory Operations, Pfizer Medical, Milan, Italy
  1. Correspondence to Piero Impicciatore, Safety Evaluation and Reporting, Worldwide Safety and Regulatory Operations, Pfizer Medical, Via Lorenteggio, 257, 20152 Milan, Italy; piero.impicciatore{at}pfizer.com
  • Accepted 6 June 2011
  • Published Online First 25 July 2011

In 2007, the International Society for Pharmacoepidemiology (ISPE) and the International Society of Pharmacovigilance (ISoP) released guidelines for publishing case reports on adverse drug reactions (ADRs). These guidelines describe what authors should consider when constructing an ADR case report for publication in terms of key information about the affected patient, administered drugs, reported reaction, causality assessment and implications for clinical practice.1

In this study, we assessed the adherence to ISPE/ISoP guidelines for ADR case reports of paediatric patients published from January 2008 to December 2010 and entered in Pfizer's safety database. We also developed a case report quality score by assigning a value …

Free sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article